title: Extension of Bolar exemption law: what will this mean for UK drug research?
authors.affiliation: 1Hogan Lovells International LLP, Atlantic House, Holborn Viaduct, London, EC1A 2FG.
authors.forename: Stephen
authors.initials: S
authors.lastname: Bennett
authors.affiliation: 1Hogan Lovells International LLP, Atlantic House, Holborn Viaduct, London, EC1A 2FG.
authors.forename: Ian
authors.initials: I
authors.lastname: Moss
mesh_terms: D035843:Biomedical Research; D016568:Drugs, Generic; D005062:European Union; D007880:Legislation, Drug; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D006113:United Kingdom
chemical_list: D016568:Drugs, Generic